Saturday, August 23, 2014

FDA Approves Human Trials, Islet Replacement

FDA approves clinical trials for "..... type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™. The company plans to immediately initiate the first ever clinical evaluation of a stem cell-derived islet replacement therapy for the treatment of people with T1D. The trial will enroll approximately 40 people at multiple clinical sites."

http://jdrf.org/blog/2014/jdrf-partner-viacyte-to-immediately-initiate-type-1-diabetes-clinical-trial/

No comments:

Post a Comment